{
  "actionable": [
    {
      "title": "Pfizer: Post-COVID Revenue Diversification Strategy",
      "url": "https://www.trefis.com/stock/pfe/analysis/revenue-diversification"
    },
    {
      "title": "Johnson & Johnson: Pharmaceutical Pipeline Value",
      "url": "https://www.trefis.com/stock/jnj/analysis/pharma-pipeline"
    },
    {
      "title": "Moderna: mRNA Platform Expansion Opportunities",
      "url": "https://www.trefis.com/stock/mrna/analysis/mrna-platform"
    },
    {
      "title": "AbbVie: Humira Patent Cliff Impact Assessment",
      "url": "https://www.trefis.com/stock/abbv/analysis/humira-patent"
    },
    {
      "title": "Gilead Sciences: Oncology Portfolio Growth",
      "url": "https://www.trefis.com/stock/gild/analysis/oncology-growth"
    }
  ],
  "featured": [
    {
      "title": "GLP-1 Drugs: Transforming Diabetes and Obesity Treatment",
      "url": "https://www.trefis.com/analysis/glp1-drugs-transformation"
    },
    {
      "title": "Biosimilars Impact: Patent Cliff Challenges for Big Pharma",
      "url": "https://www.trefis.com/analysis/biosimilars-patent-cliff"
    },
    {
      "title": "Gene Therapy: Commercial Breakthrough or Overhyped?",
      "url": "https://www.trefis.com/analysis/gene-therapy-breakthrough"
    },
    {
      "title": "Healthcare AI: Diagnostic Revolution Investment Themes",
      "url": "https://www.trefis.com/analysis/healthcare-ai-diagnostics"
    }
  ],
  "bestWorst": {
    "best": {
      "title": "Eli Lilly (LLY) - GLP-1 Drug Success",
      "url": "https://www.trefis.com/stock/lly"
    },
    "worst": {
      "title": "Moderna (MRNA) - Post-Pandemic Decline",
      "url": "https://www.trefis.com/stock/mrna"
    }
  }
}